Sign in

CIK 0001640266

  • Accelerated filer
  • Smaller reporting company

Voyager Therapeutics, Inc.

Sign in to watch
Ticker
VYGR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-259-5340
Business address
75 HAYDEN AVENUE, LEXINGTON, MA, 02421
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-06-06 Higgins Michael J Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2022-06-06 Vitale Nancy Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2022-06-06 PIERCE GLENN Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2022-04-04 Swartz Robin Chief Operating Officer Sale −1,527 $8.25 $13K 52,060
2022-04-04 Hesslein Robert W. Senior VP & General Counsel Sale −2,786 $8.25 $23K 114,963
2022-03-22 Sandrock Alfred President and CEO Grant or award +100,000 100,000
2022-03-22 Sandrock Alfred President and CEO Grant or award · Stock Option (Right to Buy) +940,600 940,600
2022-03-21 Swartz Robin Chief Operating Officer Sale −4,362 $8.29 $36K 53,638
2022-03-21 Swartz Robin Chief Operating Officer Sale −51 $8.68 $443 53,587
2022-03-21 Hesslein Robert W. Senior VP & General Counsel Sale −4,897 $8.29 $41K 117,807
2022-03-21 Hesslein Robert W. Senior VP & General Counsel Sale −58 $8.68 $503 117,749
2022-03-21 Burek Julie VP, Finance Sale −2,618 $8.29 $22K 52,489
2022-03-21 Burek Julie VP, Finance Sale −31 $8.68 $269 52,458
2022-02-17 Hesslein Robert W. Senior VP & General Counsel Sale −4,100 $3.55 $15K 122,704
2022-02-17 Burek Julie VP, Finance Sale −789 $3.55 $3K 55,107
2022-02-11 Hesslein Robert W. Senior VP & General Counsel Sale −3,252 $3.36 $11K 126,804
2022-02-11 Burek Julie VP, Finance Sale −361 $3.36 $1K 55,896
2022-02-07 Swartz Robin Chief Operating Officer Grant or award · Stock Option (Right to Buy) +65,000 65,000
2022-02-07 Sandrock Alfred Director Grant or award · Stock Option (Right to Buy) +44,000 44,000
2022-01-13 Burek Julie VP, Finance Grant or award +10,000 56,257

Page 10 of 19 · 368 trades